Advertisement
Research ArticleNeuropharmacology

Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation

Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov
Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173

Abstract

To evaluate the possible role of the plasma membrane Na+/Ca2+-exchanger (NCX) in regulation of N-methyl-d-aspartate (NMDA) receptors (NMDARs), we studied effects of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea methanesulfonate (KB-R7943; KBR) and lithium (inhibitors of NCX) on NMDA-elicited whole-cell currents using the patch-clamp technique on rat cortical neurons and human embryonic kidney 293T cells expressing recombinant NMDARs. KBR inhibited NMDAR currents in a voltage-independent manner with similar potency for receptors of GluN1/2A and GluN1/2B subunit compositions that excludes open-channel block and GluN2B-selective inhibition. The inhibition by KBR depended on glycine (Gly) concentration. At 30 μM NMDA, the KBR IC50 values were 5.3 ± 0.1 and 41.2 ± 8.8 μM for 1 and 300 μM Gly, respectively. Simultaneous application of NMDA + KBR in the absence of Gly induced robust inward NMDAR currents that peaked and then rapidly decreased. KBR, therefore, is an agonist (EC50 is 1.18 ± 0.16 µM) of the GluN1 subunit coagonist binding sites. The decrease of NMDA-elicited currents in the presence of KBR was abolished in Ca2+-free solution and was not observed in the presence of extracellular Ca2+ on 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid-loaded neurons, suggesting that Ca2+ affects NMDARs from the cytosol. In agreement, the substitution of Li+ for extracellular Na+ caused a considerable decrease of NMDAR currents, which was not observed in the absence of extracellular Ca2+. Most likely, the accumulation of intracellular Ca2+ is caused by the inhibition of Ca2+ extrusion via NCX. Thus, KBR and Li+ provoke Ca2+-dependent receptor inactivation due to the disruption of Ca2+ extrusion by the NCX. The data reveal the role of NCX in regulation of Ca2+-dependent inactivation of NMDARs.

Introduction

In the central nervous system, the plasma membrane sodium-calcium exchanger (NCX) plays an important role in neuronal calcium homeostasis. In the forward transport mode, the NCX lowers cytosolic Ca2+ by extruding one Ca2+ accompanied by the entry of three extracellular Na+ ions into the cell (Blaustein and Lederer, 1999). Under normal conditions, inhibition of NCX causes an elevation of intracellular Ca2+ concentration (Mattson et al., 1989) and forces normally nonexcitotoxic glutamate concentrations to produce a lethal Ca2+ overload (Bano et al., 2005). During excitotoxic stress, the excessive Na+ and Ca2+ entry into the cytoplasm results in loss of the Na+ gradient and thus of driving force for Ca2+ extrusion, which turns the NCX into the reverse mode of exchange. The NCX in reverse mode produces additional Ca2+ entry (Kiedrowski et al., 1994; Hoyt et al., 1998) and contributes to Ca2+ deregulation (Khodorov, 2004), promoting apoptotic neuronal death in stroke and brain trauma. Inhibition of the NCX in the reverse mode is a promising approach to decrease Ca2+ deregulation and glutamate excitotoxicity. KB-R7943 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl] isothiourea methanesulfonate (KB-R7943; Fig. 1) was the first discovered selective blocker of the NCX in reverse mode (Iwamoto et al., 1996; Watano et al., 1996). Since that time, KB-R7943 (KBR) has been a widely used inhibitor of NCX. This compound demonstrates neuroprotection in stroke, ischemia, glutamate receptor overactivation, and hypoxia (Schroder et al., 1999; Breder et al., 2000; Li et al., 2000; MacGregor et al., 2003; Luo et al., 2007). Recently, it has been demonstrated that KBR is able to inhibit both the forward and the reverse modes of NCX activity. For example, its IC50 for fish NCXs is 1.9 and 3 μM for the reverse and forward modes of action, respectively (Abramochkin et al., 2013). In cultured cortical neurons, 10 μM KBR caused an immediate rise of intracellular Ca2+, suggesting inhibition of NCX forward mode of transport (Sibarov et al., 2012).

Fig. 1.
Fig. 1.

Chemical structure of KB-R7943.

Whereas KBR has great potential for experimental and therapeutic usage, this compound exhibits additional effects that influence neuronal survival, including inhibition of L-type voltage-gated Ca2+ channels (Ouardouz et al., 2005), suppression of store-operated Ca2+ influx in cultured neurons and astrocytes (Arakawa et al., 2000), inhibition of N-methyl-d-aspartate (NMDA) receptors (NMDARs; Sobolevsky and Khodorov, 1999; Brustovetsky et al., 2011), and inhibition of mitochondrial complex I in rat cultured hippocampal neurons (Brustovetsky et al., 2011).

Inhibition of NMDARs by KBR can potentially contribute to neuronal survival during excitotoxic stress by limiting glutamate-induced calcium overload via NMDAR channels. Although possible KBR neuroprotective effects that are realized through inhibition of NMDARs represent a subject of great interest, the mechanisms of KBR action on NMDARs is still not clearly understood. Here, we study the effects of KBR on NMDARs in a wide range of KBR concentrations and demonstrate that KBR is an agonist of the coagonist binding site on the GluN1 subunit. Currents activated by NMDA + KBR exhibit strong Ca2+-dependent NMDAR desensitization most likely due to the impairment of intracellular local Ca2+ homeostasis determined by the inhibition of Ca2+ extrusion via NCX. In agreement, Li+, a substrate inhibitor of the NCX, induces Ca2+-dependent inactivation of NMDAR currents as well. This reveals the role of NCX in regulation of Ca2+-dependent inactivation of NMDARs.

Materials and Methods

Primary Culture of Cortical Neurons.

The procedure of culture preparation from embryos was previously described (Antonov and Johnson, 1996; Mironova et al., 2007). All procedures using animals were in accordance with recommendations of the Federation for Laboratory Animal Science Associations and approved by the local Institutional Animal Care and Use Committees. Female Wistar rats (provided by the Sechenov Institute’s animal facility, St. Petersburg, Russia) that were 16 days pregnant (14 animals overall in this study) were sacrificed by CO2 inhalation. Both male and female embryos were used as tissue donors. Fetuses were removed, and their cerebral cortices were isolated, enzymatically dissociated, and used to prepare primary neuronal cultures. Cells were used for experiments after 10–15 days in culture (Mironova et al., 2007; Han and Stevens, 2009). Cells were grown in Neurobasal culture medium supplemented with B-27 (Gibco-Invitrogen, Paisley, UK) on glass coverslips coated with poly-d-lysine.

Human Embryonic Kidney 293 Cells with Recombinant NMDAR.

Human embryonic kidney (HEK) 293T cells were maintained as previously described (Qian et al., 2005). HEK293T cells were plated onto 7-mm glass coverslips pretreated with poly-l-lysine (0.2 mg/ml) in 35-mm culture dishes at 1 × 105 cells per dish. Eighteen to 24 hours after plating, cells were transiently transfected with pcDNA1 encoding rat NMDA receptor subunits GluN2A and GluN2B and pcDNA3.1 encoding GluN1 and enhanced green fluorescent protein using FuGene HD reagent (Promega, Madison, WI). In brief, transfection was performed by adding to each dish 50 μl of serum-free medium containing 1 μg of total DNA and 2 μl FuGene. The ratio of cDNA used was 1 enhanced green fluorescent protein:1 GluN1:3 GluN2 (A or B). After incubation of cells for 6–8 hours, the transfection solution was replaced with fresh culture medium containing 200 μM DL-2-amino-5-amino-5-phosphono-valeric acid and 2 mM Mg2+ to prevent NMDA receptor–mediated excitotoxicity. Experiments were performed 24–72 hours after transfection.

Loading of BAPTA AM.

Neurons were loaded with BAPTA AM (1 μM) using conventional protocols. In brief, neuronal cultures were incubated with BAPTA AM and 0.02% Pluronic F-127 (Sigma-Aldrich, St. Louis, MO) added to the external solution for 20 minutes in the dark at 20–23°C. Then, BAPTA AM was washed out, and cells were incubated in the external solution for a further 30 minutes.

Patch Clamp Recordings.

Whole-cell patch clamp recordings of membrane currents were performed on cultured rat cortical neurons (10–15 days in vitro) and HEK293T cells expressing recombinant NMDARs of GluN1/2A or GluN1/2B composition. We used a MultiClamp 700B patch clamp amplifier with a Digidata 1440A acquisition system controlled by pClamp v10.2 software (Molecular Devices, Sunnyvale, CA). The acquisition rate was 20,000 seconds−1. The signal was 8-order low-pass Butterworth filtered at 200 Hz to remove high-frequency noise. Micropipette positioning was performed with an MP-85 micromanipulator (Sutter Instrument Company, Novato, CA) under the visual control of a Nikon Diaphot TMD microscope (Nikon, Tokyo, Japan). For fast medium exchange, we used a BPS-4 fast perfusion system (Ala Scientific Instruments, Farmingdale, NY). The tip of the multichannel manifold was placed at a distance of 0.2 mm from the patched cell, which allowed the solution exchange in 80 ms. Unless otherwise specified, the following extracellular medium was used for recording (the external bathing solution, in mM): 140 NaCl; 2.8 KCl; 1.0 CaCl2; and 10 HEPES, at pH 7.2–7.4. Patch pipette solution had the following composition (in mM): 120 CsF, 10 CsCl, 10 EGTA, and 10 HEPES. The pH was adjusted to 7.4 with CsOH. Patch pipettes (2–4 MΩ) were pulled from 1.5-mm (outer diameter) borosilicate standard wall capillaries with inner filament (Sutter Instrument Company). Experiments were performed at room temperature (23–25°C). The default membrane voltage (Vm) was set to −55 mV for neurons and −35 mV for HEK293T cells.

Functional activity of NMDARs requires binding of both glutamate and a coagonist, glycine. Unless otherwise stated, to activate NMDARs, we applied 30 μM NMDA with 30 μM glycine (Gly). The current voltage (I-V) relations of NMDA-induced conductance were determined by subtraction of the current recorded during a control voltage ramp from the current obtained in the presence of either NMDA + Gly or NMDA + Gly + KBR (10 μM). For NMDA + Gly + KBR, the control was measured in the external bathing solution + KBR. I-V relationships and membrane holding voltages were corrected for the liquid junction potential (approximately −15 mV; see Neher, 1992). Taking into account the value of pipette liquid junction potential, the actual ramp voltage range was from −60 to +50 mV.

Drugs.

KB-R7943 was from Tocris (Minneapolos, MO). Other compounds were from Sigma-Aldrich (St. Louis, MO). Mammalian expression vectors were supplied by Dr. J. W. Johnson (University of Pittsburgh, Pittsburgh, PA).

Data Analysis.

Quantitative data are expressed as means ± S.E.M. Analysis of variance (ANOVA) and Bonferroni multiple comparison methods as well as Student’s two-tailed t tests were used for statistical analysis. The number of experiments is indicated by n throughout. The data were considered as significantly different based on a confidence level of 0.05. Current measurements and I-V graphs were plotted using ClampFit 10.2 (Molecular Devices). The EC50 (half-maximal effective concentration for KBR as an agonist), IC50 (half-maximal concentration for KBR as an inhibitor), and Hill coefficient (h) were estimated by fitting dose-response curves with the Hill equation, I[C]/Imax = 1 / (1 + [KBR]b/C50b), where C50 represents IC50 or EC50. For IC50, the Imax is the current elicited by NMDA + Gly at 0 KBR and b = h, and for EC50, the Imax is the current elicited by NMDA + KBR at 0 Gly and b = −h. I[C] is the current, measured at different [KBR]s.

Results

Voltage Independence of KBR Block of NMDARs.

We first studied KBR effects on the cellular conductance, because the ion exchange by NCX is electrogenic, and an inhibition of KBR could potentially interfere with measurements of NMDAR-mediated currents. In the majority of cells, the effect of KBR on transmembrane currents was rather small and did not considerably affect the resting I-V relationships. Considering the large amplitudes of NMDA-activated currents in neurons, we may conclude that the KBR block of NCX transport currents may not strongly affect amplitude measurements. Because KBR is able to inhibit voltage-sensitive Na+ and L-type Ca2+ channels (Watano et al., 1996; Török, 2007), we also tested the effects of tetrodotoxin (0.5 μM) and nifedipine (10 μM) on KBR-blocked currents. Neither compound affected the I-V relationships of NCX transport currents. We therefore ignored these KBR effects as factors that could complicate interpretation of our data in further experiments.

To get some clues into the mechanism of KBR inhibition of NMDARs, we performed experiments in which NMDA-induced currents were studied over a wide range of Vm values (from −85 to +45 mV) using application of NMDA + Gly and KBR at a single voltage and the ramp protocol. At Vm = −85 mV, 10 μM KBR inhibited the NMDA-induced currents to approximately 30% of the steady-state amplitude (Fig. 2A), which is consistent with previously published data (Sobolevsky and Khodorov, 1999; Brustovetsky et al., 2011). The voltage dependence of block may provide key information about the mechanism of compound action. Interestingly, when we studied the effect of KBR at Vm = +45 mV, the inhibition of currents transferred through NMDAR channels was found similar to that obtained at Vm = −85 mV (Fig. 2A). This observation was confirmed in experiments with ramp protocols in which currents elicited by NMDA + Gly and in NMDA + Gly + KBR were recorded in the Vm range of −60 mV to +50 mV (Fig. 2B). The fraction of blocked current at various Vm values (−85, −55, −25, and +45 mV) did not differ significantly (P > 0.5, ANOVA, Fig. 2C), suggesting that inhibition of NMDARs is voltage-independent. This suggests that the block of NMDARs by KBR is not related to the open-channel block.

Fig. 2.
Fig. 2.

The voltage independence of inhibition of NMDA-induced current by 10 μM KBR. (A) Whole-cell currents induced by 30 μM NMDA + 30 μM Gly in the absence and presence of 10 μM KBR recorded at −85 and +45 mV. Application protocols are indicated above the records. (B) The I-V relations of NMDAR currents induced by 30 μM NMDA + 30 μM Gly in the absence and the presence of 10 μM KBR within the range of Vm values from −60 to +50 mV. The insert shows the applied voltage ramp protocol. (C) The fraction of NMDA-induced currents inhibited by 10 μM KBR at several Vm values (−85, −55, −25, and +45 mV). Protocol of measurements was similar to those indicated in (A). The mean values ± S.E.M. from five experiments are plotted.

KBR Effect Is Not GluN2 Subunit–Dependent.

Many compounds (for review, see Traynelis et al., 2010) reveal voltage-independent noncompetitive antagonism of NMDARs. Some of them, including ifenprodil (Williams, 1993; Whittemore et al., 1997) and Co 101244 (Zhou et al., 1999), are selective for NMDARs that contain the GluN2B subunit. To study whether KBR has selectivity for NMDARs containing GluN2A or GluN2B subunits, we performed experiments on neurons utilizing a pharmacological approach and on transfected HEK293T cells expressing recombinant NMDARs of GluN1/2A or GluN1/2B subunit compositions. Figure 3, A and B demonstrates the effects of KBR and ifenprodil on currents evoked by activation of native NMDARs in neurons. Whereas ifenprodil at 1 μM selectively inhibits GluN2B subunit–containing NMDARs, in different neurons it induces a variable degree of current inhibition from very weak (Fig. 3A) to complete block (Fig. 3B). KBR at 10 μM revealed similar inhibitions (Fig. 3, A and B) in all experiments. Since the experiments on native NMDARs do not provide conclusive evidence, we therefore undertook experiments on recombinant NMDARs consisting of GluN1/2A or GluN1/2B subunits expressed in HEK293T cells (Fig. 3, C and D). KBR at 10 μM effectively inhibited currents elicited by activation of both GluN1/2A (Fig. 3C) and GluN1/2B (Fig. 3D) receptors by 85 ± 5% (n = 3) and 73 ± 9% (n = 3), respectively. Data obtained on native (neurons, n = 5) and recombinant (HEK293T cells, n = 3) NMDARs are summarized in Fig. 3E and did not differ significantly between conditions under study (P > 0.2, ANOVA, Fig. 3E). This may suggest that KBR does not distinguish between GluN2A and GluN2B subunits and does not bind to the ifenprodil binding sites. Therefore, KBR binding requires a site that would have to be similar on GluN2A and GluN2B subunits or KBR may interfere with NMDAR function via an interaction with the GluN1 subunit.

Fig. 3.
Fig. 3.

The KBR inhibition of native and recombinant NMDARs. (A and B) Currents evoked by 30 μM NMDA + 30 μM Gly in the absence and the presence of 10 μM KBR or 1 μM ifenprodil (Ifen) in cortical neurons at Vm = −55 mV. Application protocols are indicated above the records. (C and D) Currents evoked by 30 μM NMDA + 30 μM Gly in the absence and presence of 10 μM KBR in HEK293T cells expressing GluN1/2A (C) and GluN1/2B (D) NMDARs at Vm = −35 mV. Application protocols are indicated above the records. (E) Quantitative comparison of 10 μM KBR inhibition of currents activated by 30 μM NMDA + 30 μM Gly mediated by native NMDARs (Ifen-sensitive and Ifen-resistant, n = 5 for each group) and recombinant NMDARs of GluN1/2A and GluN/2B subunit compositions (HEK293T cells, n = 3 for each group). Ordinate represents the relative inhibition of currents by 10 μM KBR measured as (1 − INMDA+KBR/INMDA), where INMDA (pA) is an amplitude of current in the absence of KBR and INMDA+KBR (pA) is an amplitude of current in the presence of KBR. The mean values ± S.E.M. are plotted. Data do not differ significantly (P > 0.2, ANOVA).

GluN1 Subunit as a Target for KBR Action.

We further studied possible competitive antagonism of KBR at glycine binding sites, which are located on GluN1 subunits. We investigated the KBR effects within the concentration range of 0.5–200 μM on 30 μM NMDA–activated whole-cell currents in the presence of 1, 30, or 300 μM Gly (Fig. 4). Notably, the concentrations of KBR required for similar inhibition of currents at 300 μM glycine were much larger than in the presence of 1 μM (Fig. 4A). Average data from 12 experiments are summarized in the concentration-inhibition curves for KBR (Fig. 4B). These curves were fitted using the Hill equation with the following parameters: for 1 μM Gly, KBR IC50 = 5.3 ± 0.1 μM and Hill coefficient (h) = 2.7 ± 0.3 (n = 4); for 30 μM Gly, IC50 = 15.0 ± 1.2 μM and h = 2.0 ± 0.1 (n = 4); and for 300 μM Gly, IC50 = 41.2 ± 8.8 μM and h = 1.0 ± 0.1 (n = 4). The IC50 values are significantly different for all Gly concentrations under study (P < 0.01, ANOVA, post-hoc Bonferroni test). Therefore, the IC50 of KBR inhibition of NMDA-induced currents increases with the increase of Gly concentration, suggesting that KBR competes with Gly for the Gly binding sites on GluN1 subunits of NMDARs. The observed tendency of a decrease of the Hill coefficient values with rising Gly concentration, however, suggests a more complex mechanism of current inhibition by KBR, rather than simple competitive antagonism.

Fig. 4.
Fig. 4.

The KBR block of NMDARs depends on glycine concentration. (A) Currents elicited by 30 μM NMDA in the presence of 1 μM (left) and 300 μM glycine (right) recorded in the presence of the indicated KBR concentrations at Vm = −55 mV. Application protocols are indicated above the records. (B) KBR concentration-inhibition curves for currents activated by 30 μM NMDA in the presence of the indicated glycine concentrations (1, 30, and 300 μM). The mean values ± S.E.M. from four experiments for each condition are plotted. Solid lines indicate fits of the data with the Hill equation with the following parameters: for 1 μM Gly, KBR IC50 = 5.3 ± 0.1 μM and Hill coefficient (h) = 2.7 ± 0.3; for 30 μM Gly, IC50 = 15.0 ± 1.2 μM and h = 2.0 ± 0.1; and for 300 μM Gly, IC50 = 41.2 ± 8.8 μM and h = 1.0 ± 0.1. The IC50 values are significantly different for all Gly concentrations under study (P < 0.01, ANOVA, post-hoc Bonferroni test). (C) KBR concentration-inhibition curves for currents activated by 10, 30, and 100 μM NMDA in the presence of 30 μM glycine. The mean values ± S.E.M. from four experiments for each condition are plotted. Solid lines indicate fits of the data with the Hill equation. KBR IC50 values were 12.9 ± 1.5 μM (h = 1.8 ± 0.2), 15.0 ± 1.2 μM (h = 1.8 ± 0.2), and 15.6 ± 1.2 μM (h = 1.9 ± 0.4) for 10, 30, and 100 μM NMDA, respectively, and did not differ significantly (P > 0.4, ANOVA).

In addition, we tested possible antagonism of KBR at the glutamate binding sites on GluN2. Currents elicited by 10, 30, and 100 μM NMDA in the presence of 30 μM Gly were blocked by KBR with similar IC50 values (Fig. 4C). KBR IC50 values were 12.9 ± 1.5 μM (h = 1.8 ± 0.2, n = 4), 15.0 ± 1.2 μM (h = 1.8 ± 0.2, n = 4), and 15.6 ± 1.2 μM (h = 1.9 ± 0.4, n = 4) for 10, 30, and 100 μM NMDA, respectively, and did not differ significantly (P > 0.4, ANOVA). This observation suggests the lack of KBR interaction with glutamate recognition sites.

KBR as an Agonist of NMDAR Coagonist Binding Sites.

To obtain more evidence in favor of competition between Gly and KBR, we undertook experiments in which NMDAR currents were activated by various Gly concentrations when 30 μM NMDA and 10 μM KBR were already present in the external bathing solution. We expected that, at concentrations of NMDA and KBR used in this series of experiments, the recognition of glutamate binding sites and the KBR binding sites that are responsible for the NMDAR inhibition will be predominantly occupied, and the channels will be closed. Then, in case of competition between Gly and KBR, it is predicted that the amplitude of current response caused by Gly application should depend on [Gly]. In Fig. 5A, 30 μM NMDA + 30 μM Gly can be seen to induce typical NMDA-activated current. In the presence of 30 μM NMDA + 10 μM KBR, applications of 1, 30, and 300 μM Gly caused NMDAR currents which were substantially smaller than the current caused by NMDA + Gly in the absence of KBR, presumably because of KBR inhibition. The amplitude of current evoked by 1 μM Gly was much smaller than the amplitude of current evoked by 30 μM Gly, and the current caused by the application of 30 μM Gly was much smaller than the current activated by 300 μM Gly. This observation demonstrates that the degree of NMDAR inhibition by 10 μM KBR depends on [Gly] and is consistent with competition of Gly and KBR for the NMDAR coagonist binding sites. In the experiments illustrated in Fig. 5B, NMDAR currents were triggered by 30 and 100 μM Gly in the presence of 30 μM NMDA + 10 μM KBR. The current activated by 100 μM Gly is much larger than that activated by 30 μM Gly. However, the amplitude of current caused by 100 μM Gly when the KBR concentration was increased to 33 μM to keep the same [KBR]/[Gly] as for 30 μM Gly was similar to the amplitude of current activated by 30 μM Gly in the presence of 10 μM KBR. This suggests that there is a reciprocal relationship between [KBR] and [Gly] in terms of NMDAR inhibition, which is also consistent with competitions between these two ligands for the same binding sites in NMDARs.

Fig. 5.
Fig. 5.

Relief from KBR inhibition by increasing the Gly concentration. (A) Currents elicited by applications of 30 μM NMDA + 30 μM Gly and 1 μM Gly (1), 30 μM Gly (2), and 300 μM Gly (3) in the presence of 30 μM NMDA + 10 μM KBR recorded at Vm = −55 mV in a neuron. Application protocols are shown above the trace. The insert represents an overlay of Gly-induced currents replotted at a higher time resolution. (B) Currents elicited by applications of 30 μM NMDA + 30 μM Gly and 30 μM Gly (1), 100 μM Gly (2) in the presence of 30 μM NMDA + 10 μM KBR, and 100 μM Gly (3) in the presence of 30 μM NMDA + 33 μM KBR recorded at Vm = −55 mV in a neuron. Application protocols are shown above the trace by solid lines. The insert represents an overlay of Gly-induced currents replotted at a higher time resolution.

We noticed that NMDA and KBR applied simultaneously (without Gly) induce a peak inward current followed by a steady-state current (Fig. 5, A and B). This could be interpreted as KBR being a partial agonist or agonist of the NMDAR coagonist binding sites. In further experiments, we therefore tested this possibility. Either KBR or NMDA applied alone did not induce considerable inward currents (Fig. 6A). Whereas 30 µM NMDA with 30 µM Gly induced a typical large inward current that reached the peak and then declined a little to the steady state, 30 µM NMDA with 10 µM KBR induced a robust inward peak current that declined quickly to a steady state of small current amplitude (Fig. 6A). The amplitude at the steady state was approximately 1/7 of the peak amplitude. The previously described observation suggests that KBR is an agonist of the NMDAR coagonist binding sites that causes fast desensitization of NMDARs. Based on this hypothesis, KBR inhibition of NMDA-induced currents may represent NMDAR desensitization induced by KBR binding.

Fig. 6.
Fig. 6.

Dependence of currents elicited by NMDA + KBR on extracellular Ca2+. (A) Currents recorded in a neuron at Vm = −55 mV elicited by application of KBR alone or NMDA alone, their simultaneous application (NMDA + KBR), and application of NMDA + Gly. Application protocols are shown above the trace. (B) NMDA + KBR elicited currents recorded in a neuron at Vm = −55 mV in the presence and absence of Ca2+ in the external bathing solution. Application protocols are shown above the trace by solid lines. (C) Currents recorded in the same neuron at Vm = −55 mV elicited by NMDA + KBR (left record) and NMDA + Gly (right record) in the Ca2+-free solution. KBR (10 µM) was added for a short episode in the middle of NMDA + Gly application. Application protocols are shown above the trace. (D) The NMDAR-mediated current activated by 100 μM NMDA + 10 μM KBR in a neuron at Vm = ;−55 mV in the Ca2+-free solutions. Kynurenate (Kyn; 50 µM) was added for a short episode in the middle of NMDA + KBR application. The application protocol is shown above the trace. (E) Currents activated by 30 μM NMDA + 10 μM KBR in a neuron at Vm = −55 mV in the presence of 1 mM Ca2+ in the external bathing solution (left record) and in the Ca2+-free solutions (right record). Ca2+ (1 mM) was added for a short episode in the middle of NMDA + KBR application. Application protocols are shown above the trace by solid lines. (F) Quantitative comparison of steady-state amplitudes of currents activated by 30 μM NMDA + 10 μM KBR in neurons in the absence (n = 7) and presence (n = 7) of 1 mM Ca2+ in the external bathing solution and when 1 mM Ca2+ is applied for a short period of time (n = 3). *Data differ significantly (P < 0.0001, ANOVA, post-hoc Bonferroni test). (G) NMDAR-mediated currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV loaded with BAPTA in the presence of 1 mM Ca2+ in the external bathing solution and in the Ca2+-free media. (H) Quantitative comparison of steady-state amplitudes of currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in BAPTA-loaded neurons in the absence (n = 6) and presence (n = 6) of 1 mM Ca2+ in the external bathing solution. Data do not differ significantly (P > 0.1, ANOVA). The mean amplitude for four recorded currents (G) in each experiment was taken for 100%.

Ca Dependence of KBR Inhibition of NMDARs.

To study whether Ca2+-dependent inactivation of NMDARs contributed to the inhibition of NMDA-induced currents by KBR, we measured currents in neurons activated by combined applications of 30 µM NMDA and 10 µM KBR in the presence and absence of Ca2+ in the external bathing solution. Whereas currents evoked by NMDA + KBR in the presence of 1 mM Ca2+ increased to a peak and then declined to a steady state of small amplitude (Fig. 6, A and B), when Ca2+ was removed from the extracellular bathing solution, the amplitudes of currents at the steady state largely increased (Fig. 6B). In many experiments, amplitudes of currents in Ca2+-free solution elicited by NMDA + Gly and NMDA + KBR were similar (Fig. 6C). Apparently, Ca2+-dependent inactivation of NMDARs contributes to the decrease of the current amplitude when KBR is used as a coagonist of NMDARs. In agreement, in the absence of extracellular Ca2+, we did not find any inhibition of NMDA + Gly–elicited current by 10 µM KBR (Fig. 6C) in the experimental protocol used to study KBR inhibition of NMDARs (Figs. 2–4), whereas kynurenate (50 µM), a competitive antagonist of Gly binding sites, inhibited currents activated by NMDA + KBR. On average, the amplitude of currents evoked by NMDA + KBR at the steady state was 239 ± 21 pA (n = 4) and decreased in the presence of 50 µM kynurenate to 19 ± 6 pA (n = 4, P < 0.0001, Student’s two-tailed t test), further supporting our conclusion that KBR and Gly bind to the same binding sites (Fig. 6D). These observations may suggest that KBR inhibition of NMDARs results predominantly from enhancement of Ca2+-dependent inactivation.

We directly addressed this question by experiments in which NMDA + KBR–elicited currents in the presence and absence of Ca2+ in the external bathing solution were recorded in paired applications on the same neurons. In the presence of Ca2+, NMDA + KBR applications caused currents which reached the peak and then declined to a steady state of small amplitude (Fig. 6E), which is typical for these conditions (Fig. 6, A and B). When NMDA + KBR were applied to the same neuron in Ca2+-free media, the elicited currents had a similar amplitude as the peak current, recorded in the presence of Ca2+, but did not reveal the amplitude decrease as long as 1 mM Ca2+ was not added. Application of Ca2+ induced a substantial decrease of the amplitude, and its washout caused the recovery of the current amplitude (Fig. 6E). Average data (Fig. 6F) depict that current amplitudes measured at the steady stated in the presence of Ca2+ (n = 7) and in the Ca2+-free media when Ca2+ was briefly applied (n = 3) do not differ significantly, whereas they are significantly smaller than the amplitudes of NMDAR-mediated currents (n = 7) measured in the Ca2+-free solution (P < 0.0001, ANOVA, post-hoc Bonferroni test). Based on the previously described experiments, we may conclude that the decrease of NMDAR-mediated currents activated by NMDA + KBR in the presence of extracellular Ca2+ results predominantly from the enhancement of Ca2+-dependent inactivation that requires an interaction of Ca2+ with intracellular domains of NMDARs. Our experiments on neurons loaded with BAPTA support this conclusion, since in the Ca2+-free media, currents activated by NMDA + KBR and NMDA + Gly in neurons loaded with BAPTA were similar and did not demonstrate the amplitude decrease in the presence of Ca2+ in the extracellular bathing solution (Fig. 6G). Average data (Fig. 6H) depict that current amplitudes measured at the steady stated in the presence of Ca2+ (n = 6) and in the Ca-free media (n = 6) do not differ significantly (P > 0.1, ANOVA).

Lithium Enhances Ca-Dependent NMDAR Inactivation.

Li+ is widely used in therapy of mood disorders, including bipolar disorders and depression as well as suicidal behaviors (Can et al., 2014). Since Li+ is a substrate inhibitor of Na+-dependent neurotransmitter transporters (Antonov and Magazanik, 1988; Can et al., 2014) and exchangers (for review, see Török, 2007), at least a portion of its therapeutic effects is determined by this type of pharmacological action. Accordingly, the substitution of Li+ for Na+ in the external bathing solution should considerably decrease the efficacy of Ca2+ extrusion via NCX. The effects of such substitution on NMDAR kinetics and conductance is expected to be negligible, because NMDARs have similar Li+ and Na+ channel permeabilities (Karkanias and Papke, 1999). In agreement, currents activated by NMDA + Gly in our experiments on neurons in Ca2+-free Na+ and Li+ bathing solutions had similar time courses (Fig. 7, A and B, left overlay), and their steady-state amplitudes did not differ significantly (Fig. 7C, P > 0.5, n = 5, Student’s two-tailed t tests). In the presence of Ca2+ in the external bathing solutions, currents activated by NMDA + Gly revealed the amplitude decrease in both Na+ and Li+ (Fig. 7, A and B) because of the Ca2+-dependent NMDAR inactivation. The extent of Ca2+-dependent inactivation achieved in the Li+ external bathing solution was greater than in the Na+ one (Fig. 7B, right overlay), since the current amplitudes measured at the steady state under these conditions differed significantly (Fig. 7C, P < 0.01, n = 5, Student’s two-tailed t tests). This observation is consistent with the assumption that Ca2+ extrusion via NCX might be involved in the regulation of Ca2+ inactivation of NMDARs.

Fig. 7.
Fig. 7.

Li+ enhances Ca2+ inactivation of NMDAR currents. (A) Currents activated by 30 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV in the presence and absence of 1 mM Ca2+ in Na+ and Li+ external bathing solutions. Application protocols are shown above the trace by solid lines and boxes. (B) Superposition of currents depicted in (A) under certain conditions (currents indicated by different colors) for better comparison of their time courses. (C) Quantitative comparison of amplitudes of currents activated by 30 μM NMDA + 10 μM Gly measured at the steady state in the absence (n = 5) and presence (n = 5) of 1 mM Ca2+ in Na+ and Li+ external bathing solutions. *Data differ significantly (P < 0.01, Student’s two-tailed t tests).

EC50 of KBR as an NMDAR Coagonist.

In further experiments, we measured KBR EC50 for the NMDA-elicited currents. To raise the amplitude resolution of currents at the steady state, these experiments were performed in the Ca2+-free external bathing solution. At [NMDA] = 30 µM, increasing [KBR] caused an increase of NMDAR currents measured at the steady state (Fig. 8A). The dependence of the steady-state current amplitude on KBR concentration is shown in Fig. 8B. Fits of the Hill equation to the data reveal the following parameters of KBR activation: EC50 = 1.18 ± 0.16 µM (n = 5) and h = 1.5 ± 0.4 (n = 5). It should be noted that the KBR EC50 value is very similar to the EC50 for glycine and d-serine (for review, see Traynelis et al., 2010). KBR and Gly have similar efficacy as coagonists, since currents elicited by 100 µM NMDA in the presence of saturating concentrations of KBR (10 µM) or Gly (10 µM) recorded in the paired applications on the same neurons had similar amplitudes (Fig. 8C) that do not differ significantly (P > 0.7, two-tailed Student’s t test, n = 7, Fig. 8D).

Fig. 8.
Fig. 8.

Measurements of EC50 of KBR as a coagonist of NMDARs. (A) An overlay of currents elicited by NMDA + KBR at different concentrations (shown on the right of each trace) in a neuron at Vm = −55 mV in Ca2+-free solution. (B) Concentration-activation curve for KBR of currents elicited by 30 μM NMDA recorded in neurons at Vm = −55 mV in Ca2+-free external solution. The mean values ± S.E.M. from five experiments for each condition are plotted. Solid line indicates fit of the data with the Hill equation. Fit reveals the following parameters of KBR activation: EC50 = 1.18 ± 0.16 µM and h = 1.5 ± 0.4. KBR concentrations above 10 μM were not used for the fit. (C) NMDAR-mediated currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV in the Ca2+-free media. (D) Quantitative comparison of amplitudes of currents activated by 100 µM NMDA + 10 µM KBR and by 100 µM NMDA + 10 µM Gly recorded on the same neurons (n = 7) during paired applications in the Ca2+-free media. The mean values ± S.E.M. are plotted. Data do not differ significantly (P > 0.7, two-tailed Student’s t test). (E) Currents recorded in a neuron at Vm = −55 mV in Ca2+-free external solution elicited by successive applications of 30 μM NMDA + KBR at 3, 10, 30, and 100 μM. Application protocol is shown above the trace.

In addition to the KBR effects described earlier, we found that the increase of [KBR] to a rather high concentration (above 10 µM), even in the Ca2+-free external bathing solution, causes a decrease of current amplitudes (Fig. 8E). This effect may presumably be explained by weakly voltage-dependent channel block of NMDARs by KBR described previously (Sobolevsky and Khodorov, 1999) and an accumulation of Ca2+ released from the intracellular Ca2+ stores due to KBR inhibition of mitochondrial metabolism (Brustovetsky et al., 2011).

Discussion

To clarify the mechanism of KBR inhibition of NMDARs, we examined the voltage dependence of the KBR effects because such information could be crucial with respect to the mechanism. For instance, open-channel blockers of NMDARs reveal the voltage dependence of inhibition of NMDA-induced currents that is determined by the location of their binding sites in the ion pore within the membrane electric field (Woodhull, 1973) and interaction of the channel-blocking molecule or cation with permeant ions (Antonov et al., 1998; Antonov and Johnson, 1999). In our experiments, the KBR inhibition of NMDA-induced currents was not voltage-dependent (Fig. 2). We therefore may exclude channel block as a main mechanism of KBR action and suggest that KBR most likely interacts with functionally important NMDAR structures other than the ion pore. This conclusion to some extent differs from a previous study in which a portion of KBR-induced NMDAR inhibition was slightly voltage-dependent (Sobolevsky and Khodorov, 1999).

It is well known that cortical neurons express GluN1, GluN2A, and GluN2B subunits of NMDARs (Zhong et al., 1994; Mizuta et al., 1998; Abushik et al., 2013). Neurons vary substantially with respect to the GluN2A/GluN2B expression ratio (Tovar and Westbrook, 1999; Traynelis et al., 2010). The NMDAR-mediated currents in both neuronal types (ifenprodil-sensitive and -resistant) were effectively inhibited by 10 μM KBR (Fig. 3, A and B). In addition, KBR effectively inhibited currents elicited by NMDA + Gly activation of recombinant NMDARs consisting of GluN1/2A (Fig. 3C) or GluN1/2B (Fig. 3D) subunits expressed in HEK293T cells. These observations provide evidence that KBR is not selective with respect to GluN1/2A and GluN1/2B receptors and does not interact with sites on the GluN2B subunit at which subunit-specific inhibitors bind.

Based on the phenomenology of NMDAR inhibition by KBR (Figs. 2–4), one cannot exclude that this compound competes with agonists for glutamate recognition sites and with glycine (Johnson and Ascher, 1987; Kleckner and Dingledine, 1988) or d-serine (Schell et al., 1995; Wolosker et al., 1999), which are endogenous ligands at the coagonist binding sites on NMDARs. In our experiments, the values of KBR IC50 were similar when measured on currents elicited by different NMDA concentrations (10, 30, or 100 μM; Fig. 4C). This suggests a lack of competition between KBR and NMDA for the glutamate recognition sites and is consistent with the conclusion that, during inhibition, KBR does not interact with the glutamate site of GluN2 subunits of NMDARs. In contrast, increasing the Gly concentration in the range of 1–300 μM while keeping the receptor in a rather high NMDA concentration (30 μM) resulted in an 8-fold increase of the IC50 value of KBR for inhibition of NMDA-activated whole-cell currents (Fig. 4B). Moreover, the KBR inhibition decreased when NMDAR currents were successively triggered by 1, 30, and 300 µM Gly in the presence of 10 µM KBR + 30 µM NMDA (Fig. 5A). Both observations may favor competition between KBR and Gly for the coagonist binding sites on GluN1 subunits of NMDARs. It should be mentioned, however, that a 300-fold increase of [Gly] induces an 8-fold increase of the KBR IC50, and h (Hill coefficient) of KBR dose-inhibition curves falls from a value of 2 at 1 and 30 µM Gly to a value of 1 at 300 µM Gly (Fig. 4B). These peculiarities of KBR-induced NMDAR inhibition are not consistent with simple competitive inhibition at the Gly binding sites.

Indeed, in later experiments, it appeared that KBR itself is an agonist at the NMDAR coagonist binding sites. The KBR EC50 for NMDAR activation is about 1 µM (Fig. 8B), which is similar to glycine and d-serine (for review, see Traynelis et al., 2010). In Ca2+-free solution, amplitudes of currents elicited by NMDA + KBR and NMDA + Gly coincide well (Figs. 6C and 8C), suggesting that Gly and KBR have similar efficacy as coagonists of NMDARs. Simultaneous application of NMDA and KBR induced robust inward NMDAR currents, which briefly reached a peak and then demonstrated fast decrease to a steady state of about 1/7 of the peak amplitude (Fig. 6, A, B, and E). The decrease of NMDA + KBR–elicited currents was abolished (Fig. 6, B and C) by removal of Ca2+ from the external bathing solution, whereas episodic applications of extracellular Ca2+ in the course of current activated by NMDA + KBR caused the inhibition (Fig. 6E). Taken together, these data suggest that the presence of KBR in the external bathing solution somehow enforces Ca2+-dependent receptor inactivation of NMDARs, which requires an accumulation of intracellular Ca2+ in close proximity to the intracellular NMDAR structures which are responsible for Ca2+ binding (Tong and Jahr, 1994). In agreement with this assumption, loading neurons with BAPTA abolished these effects of Ca2+ on currents activated by NMDA + KBR (Fig. 6, G and H). This allows us to suggest that the impairment of intracellular local Ca2+ homeostasis is caused by the NCX inhibition that occurs within the same concentration range where KBR has an effect on NMDARs. We therefore propose the role of NCX that would restrict Ca2+ diffusion and thereby regulate local intracellular Ca2+ concentration in close proximity of intracellular domains of NMDARs. This “Ca2+ compartmentalization” may depend on the fast Ca2+ entry through NMDAR channels and on the fast membranous extrusion via the NCX. Similar interaction of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and NCX-forming calcium microdomains was demonstrated for aspiny dendrites of GABAergic interneurons (Goldberg et al., 2003). Results of our experiments with Li+ external bathing solutions are consistent with this explanation. Whereas Li+ inhibits Ca2+ extrusion from neurons via NCX (Török, 2007), it does not affect currents mediated by NMDARs (Karkanias and Papke, 1999). In agreement, NMDAR-mediated currents in Ca2+-free Na+ and Li+ external bathing solutions had similar amplitudes (Fig. 7, A and B). Addition of Ca2+ (1 mM) in the external bathing solutions caused Ca2+-dependent NMDAR inactivation, which was much more pronounced in the Li+ external bathing solution than in the Na+ one (Fig. 7), suggesting a role of NCX in regulation of Ca2+ inactivation of NMDARs.

The interpretation of our data is illustrated in Fig. 9. In the presence of extracellular Ca2+, currents activated by NMDA + Gly demonstrate typical shape (Fig. 9A, right) exhibiting moderate receptor desensitization. The capacity of Ca2+ extrusion by the NCX is sufficient to restrict lateral diffusion along the internal surface of the plasma membrane of Ca2+ that enters the cytosol through the NMDAR channels (Fig. 9A). Currents activated by NMDA + KBR exhibit strong desensitization (Fig. 9B, right), because the inhibition of Ca2+ extrusion by NCX with KBR causes local Ca2+ accumulation and Ca2+ inactivation of NMDARs (Fig. 9B). Currents activated by NMDA + Gly (Fig. 9C) or NMDA + KBR (Fig. 9D) in the Ca2+-free external solution do not reveal receptor desensitization (Fig. 9, C and D, right) because Ca2+ does not enter the cytoplasm (Fig. 9, C and D). In the presence of extracellular Ca2+, currents activated by NMDA + KBR in neurons loaded with BAPTA do not exhibit Ca2+-dependent inactivation (Fig. 9E, right) since BAPTA binds Ca2+ entered the cytosol through NMDAR channels (Fig. 9E). Thus, functional interaction of the NMDARs with the NCXs provides a plausible explanation of the phenomenology obtained in this study. Most likely, Ca2+-dependent NMDAR inactivation provides feedback between Ca2+ extrusion via NCX and Ca2+ entry through NMDAR channels: the decrease of NCX transport induces the decrease of Ca2+ entry. Within the framework of this mechanism, the dependence of the KBR inhibition of currents activated by NMDA + Gly on Gly concentration (Figs. 4 and 5) could be determined by the relief from NMDAR Ca2+-dependent desensitization by the increase of Gly concentration (Lerma et al., 1990; Danysz and Parsons, 1998). In addition, the electrochemical gradient for Ca2+ between the extracellular media (1 mM Ca2+) and the cytoplasm (about 50 nM free Ca2+), resulting in the reversal potential for Ca2+ of about +130 mV, maintains the Ca2+ entry through NMDAR channels regardless of the direction (inward or outward) of integral NMDAR ion flow. This may explain the Vm independence of the KBR inhibition of NMDAR-mediated currents within the Vm range studied here. Whether those functional interactions between the NMDARs and the NCXs include direct molecular interplay remains to be elucidated.

Fig. 9.
Fig. 9.

Schematics of the data interpretation. (A) Control conditions when Ca2+ entry from Ca2+-containing extracellular solution in neurons through NMDAR channels activated by NMDA (N) + Gly is partly compensated by the NCX Ca2+ extrusion. Typical shape of currents in these conditions is indicated to the right of the illustration. (B) In the presence of extracellular Ca2+, NMDA + KBR activates NMDAR and Ca2+ entry in the cytoplasm through the channels and inhibits Ca2+ extrusion by the NCX, which causes Ca2+ elevation around intracellular domains of NMDARs and enforces their Ca2+-dependent inactivation. Typical shape of currents in these conditions is indicated to the right of the illustration. (C and D) In the Ca2+-free extracellular solution, independent of whether the NMDARs are activated with Gly (C) or KBR (D), Ca2+ does not enter the cytoplasm and currents do not reveal desensitization. (E) In the presence of Ca2+ in the extracellular solutions, neurons loaded with BAPTA when NMDARs are activated by NMDA (N) and KBR do not reveal current desensitization since BAPTA bind Ca2+ that enter the cytoplasm through the NMDAR channels. In the illustration, INMDA is the current activated by NMDA + Gly or KBR. Other symbols have their usual meanings. For further explanation, see Discussion.

It is generally thought that KBR has the clinical potential to prevent calcium overload of neurons (Amran et al., 2003). Here, we demonstrated that KBR and Li+, which inhibit the NCX by different mechanisms, both have similar effects on NMDARs and decrease amplitudes of NMDA-activated currents, enhancing their Ca2+-dependent inactivation. Since Li+ has a broad therapeutic utility, one may not exclude that this mechanism is involved in the therapy. Therefore, inhibitors of the NCX could potentially be considered as modulators of NMDARs. In addition, KBR is an effective agonist of the glycine binding sites of NMDARs. Taking into account both effects, it seems obvious that KBR should inhibit calcium entry via NMDARs, a process that can also contribute to neuroprotection in excitotoxic stress. Glycine site antagonists and partial agonists are thought to have better therapeutic indices than glutamate site antagonists because of their lesser side effects (Chen et al., 1993; Danysz and Parsons, 1998; Wood at al., 2008). Whereas the complex effects of KBR can be beneficial to its possible clinical use in stroke treatment, it is currently hard to estimate the possible therapeutic potential of the KBR effects on NMDARs.

Acknowledgments

The authors thank Dr. J. W. Johnson for careful reading and critical suggestions on the manuscript and for providing NMDAR plasmids.

Authorship Contributions

Participated in research design: Antonov, Sibarov.

Conducted experiments: Abushik, Poguzhelskaya, Sibarov.

Contributed new reagents or analytic tools: Bolshakov.

Performed data analysis: Antonov, Sibarov.

Wrote or contributed to the writing of the manuscript: Antonov, Sibarov.

Footnotes

    • Received June 23, 2015.
    • Accepted September 18, 2015.

  • This work was supported by the Russian Foundation for Basic Research [Grants 14-04-00227 (to S.M.A.), 15-04-08283 (to D.A.S.), and 14-04-31707 (to P.A.A.)] and by the program grant (Section of Physiology and Fundamental Medicine) of Russian Academy of Sciences (to S.M.A.).

  • dx.doi.org/10.1124/jpet.115.227173.

Abbreviations

ANOVA
analysis of variance
BAPTA AM
1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester)
Co 101244
1-[2-(4-Hydroxyphenoxy)ethyl]-4-[(4-methylphenyl)methyl]-4-piperidinol hydrochloride
HEK
human embryonic kidney
I-V
current-voltage
KBR
KB-R7943 (2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea methanesulfonate)
NCX
plasma membrane sodium-calcium exchanger
NMDA
N-methyl-d-aspartate
NMDAR
N-methyl-d-aspartate receptor

References

  1. ↵
    1. Abramochkin DV,
    2. Alekseeva EI, and
    3. Vornanen M
    (2013) Inhibition of the cardiac inward rectifier potassium currents by KB-R7943. Comp Biochem Physiol C Toxicol Pharmacol 158:181–186.
    OpenUrlCrossRef
  2. ↵
    1. Abushik PA,
    2. Sibarov DA,
    3. Eaton MJ,
    4. Skatchkov SN, and
    5. Antonov SM
    (2013) Kainate-induced calcium overload of cortical neurons in vitro: Dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain. Cell Calcium 54:95–104.
    OpenUrlCrossRef
  3. ↵
    1. Amran MS,
    2. Homma N, and
    3. Hashimoto K
    (2003) Pharmacology of KB-R7943: a Na+-Ca2+ exchange inhibitor. Cardiovasc Drug Rev 21:255–276.
    OpenUrlPubMed
  4. ↵
    1. Antonov SM,
    2. Gmiro VE, and
    3. Johnson JW
    (1998) Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nat Neurosci 1:451–461.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Antonov SM and
    2. Johnson JW
    (1996) Voltage-dependent interaction of open-channel blocking molecules with gating of NMDA receptors in rat cortical neurons. J Physiol 493:425–445.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Antonov SM and
    2. Johnson JW
    (1999) Permeant ion regulation of N-methyl-D-aspartate receptor channel block by Mg2+. Proc Natl Acad Sci USA 96:14571–14576.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Antonov SM and
    2. Magazanik LG
    (1988) Intense non-quantal release of glutamate in an insect neuromuscular junction. Neurosci Lett 93:204–208.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Arakawa N,
    2. Sakaue M,
    3. Yokoyama I,
    4. Hashimoto H,
    5. Koyama Y,
    6. Baba A, and
    7. Matsuda T
    (2000) KB-R7943 inhibits store-operated Ca(2+) entry in cultured neurons and astrocytes. Biochem Biophys Res Commun 279:354–357.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bano D,
    2. Young KW,
    3. Guerin CJ,
    4. Lefeuvre R,
    5. Rothwell NJ,
    6. Naldini L,
    7. Rizzuto R,
    8. Carafoli E, and
    9. Nicotera P
    (2005) Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120:275–285.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Blaustein MP and
    2. Lederer WJ
    (1999) Sodium/calcium exchange: its physiological implications. Physiol Rev 79:763–854.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Breder J,
    2. Sabelhaus CF,
    3. Opitz T,
    4. Reymann KG, and
    5. Schröder UH
    (2000) Inhibition of different pathways influencing Na(+) homeostasis protects organotypic hippocampal slice cultures from hypoxic/hypoglycemic injury. Neuropharmacology 39:1779–1787.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Brustovetsky T,
    2. Brittain MK,
    3. Sheets PL,
    4. Cummins TR,
    5. Pinelis V, and
    6. Brustovetsky N
    (2011) KB-R7943, an inhibitor of the reverse Na+ /Ca2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I. Br J Pharmacol 162:255–270.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Can A,
    2. Schulze TG, and
    3. Gould TD
    (2014) Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav 123:3–16.
    OpenUrlCrossRef
  14. ↵
    1. Chen J,
    2. Graham S,
    3. Moroni F, and
    4. Simon R
    (1993) A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J Pharmacol Exp Ther 267:937–941.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Danysz W and
    2. Parsons CG
    (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597–664.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Goldberg JH,
    2. Tamas G,
    3. Aronov D, and
    4. Yuste R
    (2003) Calcium microdomains in aspiny dendrites. Neuron 40:807–821.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Han EB and
    2. Stevens CF
    (2009) Development regulates a switch between post- and presynaptic strengthening in response to activity deprivation. Proc Natl Acad Sci USA 106:10817–10822.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Hoyt KR,
    2. Arden SR,
    3. Aizenman E, and
    4. Reynolds IJ
    (1998) Reverse Na+/Ca2+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons. Mol Pharmacol 53:742–749.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Iwamoto T,
    2. Watano T, and
    3. Shigekawa M
    (1996) A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271:22391–22397.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Johnson JW and
    2. Ascher P
    (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529–531.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Karkanias NB and
    2. Papke RL
    (1999) Subtype-specific effects of lithium on glutamate receptor function. J Neurophysiol 81:1506–1512.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Khodorov B
    (2004) Glutamate-induced deregulation of calcium homeostasis and mitochondrial dysfunction in mammalian central neurones. Prog Biophys Mol Biol 86:279–351.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Kiedrowski L,
    2. Brooker G,
    3. Costa E, and
    4. Wroblewski JT
    (1994) Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12:295–300.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Kleckner NW and
    2. Dingledine R
    (1988) Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241:835–837.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Lerma J,
    2. Zukin RS, and
    3. Bennett MV
    (1990) Glycine decreases desensitization of N-methyl-D-aspartate (NMDA) receptors expressed in Xenopus oocytes and is required for NMDA responses. Proc Natl Acad Sci USA 87:2354–2358.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Li S,
    2. Jiang Q, and
    3. Stys PK
    (2000) Important role of reverse Na(+)-Ca(2+) exchange in spinal cord white matter injury at physiological temperature. J Neurophysiol 84:1116–1119.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Luo J,
    2. Wang Y,
    3. Chen X,
    4. Chen H,
    5. Kintner DB,
    6. Shull GE,
    7. Philipson KD, and
    8. Sun D
    (2007) Increased tolerance to ischemic neuronal damage by knockdown of Na+-Ca2+ exchanger isoform 1. Ann N Y Acad Sci 1099:292–305.
    OpenUrlCrossRefPubMed
  28. ↵
    1. MacGregor DG,
    2. Avshalumov MV, and
    3. Rice ME
    (2003) Brain edema induced by in vitro ischemia: causal factors and neuroprotection. J Neurochem 85:1402–1411.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Mattson MP,
    2. Guthrie PB, and
    3. Kater SB
    (1989) A role for Na+-dependent Ca2+ extrusion in protection against neuronal excitotoxicity. FASEB J 3:2519–2526.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Mironova EV,
    2. Evstratova AA, and
    3. Antonov SM
    (2007) A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture. J Neurosci Methods 163:1–8.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Mizuta I,
    2. Katayama M,
    3. Watanabe M,
    4. Mishina M, and
    5. Ishii K
    (1998) Developmental expression of NMDA receptor subunits and the emergence of glutamate neurotoxicity in primary cultures of murine cerebral cortical neurons. Cell Mol Life Sci 54:721–725.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Neher E
    (1992) Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol 207:123–131.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Ouardouz M,
    2. Zamponi GW,
    3. Barr W,
    4. Kiedrowski L, and
    5. Stys PK
    (2005) Protection of ischemic rat spinal cord white matter: Dual action of KB-R7943 on Na+/Ca2+ exchange and L-type Ca2+ channels. Neuropharmacology 48:566–575.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Qian A,
    2. Buller AL, and
    3. Johnson JW
    (2005) NR2 subunit-dependence of NMDA receptor channel block by external Mg2+. J Physiol 562:319–331.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Schell MJ,
    2. Molliver ME, and
    3. Snyder SH
    (1995) D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92:3948–3952.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Schröder UH,
    2. Breder J,
    3. Sabelhaus CF, and
    4. Reymann KG
    (1999) The novel Na+/Ca2+ exchange inhibitor KB-R7943 protects CA1 neurons in rat hippocampal slices against hypoxic/hypoglycemic injury. Neuropharmacology 38:319–321.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Sibarov DA,
    2. Bolshakov AE,
    3. Abushik PA,
    4. Krivoi II, and
    5. Antonov SM
    (2012) Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress. J Pharmacol Exp Ther 343:596–607.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Sobolevsky AI and
    2. Khodorov BI
    (1999) Blockade of NMDA channels in acutely isolated rat hippocampal neurons by the Na+/Ca2+ exchange inhibitor KB-R7943. Neuropharmacology 38:1235–1242.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Tong G and
    2. Jahr CE
    (1994) Regulation of glycine-insensitive desensitization of the NMDA receptor in outside-out patches. J Neurophysiol 72:754–761.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Török TL
    (2007) Electrogenic Na+/Ca2+-exchange of nerve and muscle cells. Prog Neurobiol 82:287–347.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Tovar KR and
    2. Westbrook GL
    (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19:4180–4188.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Traynelis SF,
    2. Wollmuth LP,
    3. McBain CJ,
    4. Menniti FS,
    5. Vance KM,
    6. Ogden KK,
    7. Hansen KB,
    8. Yuan H,
    9. Myers SJ, and
    10. Dingledine R
    (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405–496.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Watano T,
    2. Kimura J,
    3. Morita T, and
    4. Nakanishi H
    (1996) A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119:555–563.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Whittemore ER,
    2. Ilyin VI, and
    3. Woodward RM
    (1997) Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther 282:326–338.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Williams K
    (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851–859.
    OpenUrlAbstract
  46. ↵
    1. Wolosker H,
    2. Blackshaw S, and
    3. Snyder SH
    (1999) Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci USA 96:13409–13414.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Wood PL,
    2. Mahmood SA, and
    3. Moskal JR
    (2008) Antinociceptive action of GLYX-13: an N-methyl-D-aspartate receptor glycine site partial agonist. Neuroreport 19:1059–1061.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Woodhull AM
    (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol 61:687–708.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Zhong J,
    2. Russell SL,
    3. Pritchett DB,
    4. Molinoff PB, and
    5. Williams K
    (1994) Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol 45:846–853.
    OpenUrlAbstract
  50. ↵
    1. Zhou ZL,
    2. Cai SX,
    3. Whittemore ER,
    4. Konkoy CS,
    5. Espitia SA,
    6. Tran M,
    7. Rock DM,
    8. Coughenour LL,
    9. Hawkinson JE,
    10. Boxer PA,
    11. et al.
    (1999) 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist. J Med Chem 42:2993–3000.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleNeuropharmacology

Mechanism of KB-R7943 and Lithium Effects on NMDARs

Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov
Journal of Pharmacology and Experimental Therapeutics December 1, 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section